Literature DB >> 7680313

Characterization of a linear epitope within the human pancreatic 64-kDa glutamic acid decarboxylase and its autoimmune recognition by sera from insulin-dependent diabetes mellitus patients.

L Mauch1, C C Abney, H Berg, W A Scherbaum, B Liedvogel, W Northemann.   

Abstract

A 2.0-kb cDNA coding for the full-length 64-kDa human glutamic acid decarboxylase (GAD64) was isolated from a pancreatic carcinoma cDNA library by oligonucleotide screening, polymerase-chain-reaction amplification and subsequently characterized by sequence analysis. Five overlapping fragments of GAD64 cDNA were constructed into the vector pH6EX3, allowing the highly efficient expression of corresponding fusion proteins with a histidine hexapeptide as an affinity ligand at their N-termini in Escherichia coli. The recombinant GAD64 fragments were analysed by Western blotting using sera from patients with early onset of insulin-dependent diabetes mellitus (IDDM). We found that at least 20% of the patients with an onset of IDDM have developed autoantibodies which can specifically recognize a linear antigenic epitope within the GAD64. With a selected IDDM serum, an antigenic epitope was localized in a region of 31 amino acids located at the C-terminus of GAD64, using epitope mapping techniques, and it was characterized. The possibility of using recombinant GAD64 for the development of an immunoassay for a predictive diagnosis of IDDM is discussed.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7680313     DOI: 10.1111/j.1432-1033.1993.tb17698.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  8 in total

1.  Distinct antigenic features of linear epitopes at the N-terminus and C-terminus of 65 kDa glutamic acid decarboxylase (GAD65): implications for autoantigen modification during pathogenesis.

Authors:  T A M A Al-Bukhari; P M Radford; G Bouras; C Davenport; S M Trigwell; G-F Bottazzo; M Lai; H L Schwartz; P J Tighe; I Todd
Journal:  Clin Exp Immunol       Date:  2002-10       Impact factor: 4.330

2.  A novel heterologous gene expression system in Saccharomyces cerevisiae using the isocitrate lyase gene promoter from Candida tropicalis.

Authors:  T Kanai; H Atomi; K Umemura; H Ueno; Y Teranishi; M Ueda; A Tanaka
Journal:  Appl Microbiol Biotechnol       Date:  1996-02       Impact factor: 4.813

3.  Identification and characterization of glima 38, a glycosylated islet cell membrane antigen, which together with GAD65 and IA2 marks the early phases of autoimmune response in type 1 diabetes.

Authors:  H J Aanstoot; S M Kang; J Kim; L A Lindsay; U Roll; M Knip; M Atkinson; P Mose-Larsen; S Fey; J Ludvigsson; L Landin; J Bruining; N Maclaren; H K Akerblom; S Baekkeskov
Journal:  J Clin Invest       Date:  1996-06-15       Impact factor: 14.808

4.  Heterogeneity in the occurrence of a subset of autoantibodies to glutamic acid decarboxylase in autoimmune polyendocrine patients with islet cell antibodies.

Authors:  C Davenport; P M Radford; T A Al-Bukhari; M Lai; G F Bottazzo; I Todd
Journal:  Clin Exp Immunol       Date:  1998-03       Impact factor: 4.330

5.  High-Density Peptide Microarray Analysis of IgG Autoantibody Reactivities in Serum and Cerebrospinal Fluid of Multiple Sclerosis Patients.

Authors:  Michael Hecker; Brit Fitzner; Matthias Wendt; Peter Lorenz; Kristin Flechtner; Felix Steinbeck; Ina Schröder; Hans-Jürgen Thiesen; Uwe Klaus Zettl
Journal:  Mol Cell Proteomics       Date:  2016-02-01       Impact factor: 5.911

6.  Higher autoantibody levels and recognition of a linear NH2-terminal epitope in the autoantigen GAD65, distinguish stiff-man syndrome from insulin-dependent diabetes mellitus.

Authors:  J Kim; M Namchuk; T Bugawan; Q Fu; M Jaffe; Y Shi; H J Aanstoot; C W Turck; H Erlich; V Lennon; S Baekkeskov
Journal:  J Exp Med       Date:  1994-08-01       Impact factor: 14.307

7.  Identification of a dominant epitope of glutamic acid decarboxylase (GAD-65) recognized by autoantibodies in stiff-man syndrome.

Authors:  M H Butler; M Solimena; R Dirkx; A Hayday; P De Camilli
Journal:  J Exp Med       Date:  1993-12-01       Impact factor: 14.307

8.  Comparative analysis of different biofactories for the production of a major diabetes autoantigen.

Authors:  Linda Avesani; Matilde Merlin; Elisa Gecchele; Stefano Capaldi; Annalisa Brozzetti; Alberto Falorni; Mario Pezzotti
Journal:  Transgenic Res       Date:  2013-10-20       Impact factor: 2.788

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.